Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 June 2024 | Story Precious Shamase | Photo Suplied
Prof Jesse Lutabingwa
Prof Jesse Lutabingwa, the visiting scholar who will be facilitating grant-writing workshops to support third-stream aspirations.

The University of the Free State (UFS) welcomes Prof Jesse Lutabingwa, a visiting Fellow from the Appalachian State University (AppState) in the United States. Prof Lutabingwa arrives under the prestigious Carnegie African Diaspora Fellowship Programme (CADFP), bringing a wealth of experience to support the university's ‘third-income aspirations.’

Prof Lutabingwa’s long-standing connection with the UFS began in 2009 when he played a pivotal role in establishing a collaborative partnership between the two institutions. At the time, he was serving as Associate Vice-Chancellor for International Education and Development at AppState. Now, he returns not as an administrator, but as a faculty member eager to share his expertise and deepen this valuable connection.

"I have always wanted to participate in CADFP to give back to the African continent," Prof Lutabingwa explains. "This fellowship allows me to engage with the UFS community on different issues and contribute to the professional and individual growth of faculty, staff, and students, ultimately serving our communities better."

Empowering through grant writing

A key aspect of Prof Lutabingwa’s fellowship is a series of grant-writing workshops designed to empower UFS faculty, researchers, and postgraduate students, particularly on the Qwaqwa Campus.

"Many find the idea of proposing research grants daunting," Prof Lutabingwa says. "My goal is to elucidate the process. With more than 33 years of experience and more than 65% success rate, I am here to share the knowledge I have gained as a grant writer and reviewer."

These workshops will equip participants with the skills and strategies needed to craft compelling proposals, significantly increasing their chances of securing funding. Access to grants is crucial, Prof Lutabingwa emphasises, as it allows researchers to pursue innovative work that benefits society while offering valuable training opportunities for students.

Collaboration for research impact

Prof Lutabingwa’s contributions extend beyond workshops. He will collaborate with Dr Grey Magaiza, Director of the Centre for Gender and Africa Studies, and other faculty members on co-authoring two research articles. This collaboration aims to strengthen the UFS' research profile and contribute to a more impactful research landscape.

Dr Magaiza highlights the significance of Prof Lutabingwa’s visit: "Jesse is at the heart of the UFS-AppState partnership. Now, as a Carnegie Africa Diaspora fellow, he can engage with us in a new way, pouring his expertise back into this space. His grant-writing workshops and collaborative research efforts will be instrumental in achieving our third-stream aspirations."

Excited about the future

The fellow’s enthusiasm for this fellowship is noticeable when he speaks and engages with colleagues on campus. "Words cannot express my excitement," he shares. "I am grateful for this opportunity to collaborate, engage in research, and connect with various individuals on campus."

The UFS community warmly welcomes Prof Lutabingwa and anticipates a fruitful fellowship that will empower faculty, strengthen research, and propel the UFS – particularly the Qwaqwa Campus – towards achieving its third-income aspirations.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept